Additionally, Eyler et al. [49] provided evidence that treatment of BTSC with AKT inhibitors induces apoptosis, decreases motility and invasiveness of BTSC in vitro, and inhibits tumor growth in vivo in a xenograft model. Here, AKT1 is linked to neoplasm.